Other funders

Invention for Innovation (i4i) Product Development Awards – Call 18

Applications are invited for the NIHR Invention for Innovation (i4i) Product Development Award (PDA)  that funds the development of disruptive early stage medical technologies which  address existing or emerging healthcare needs. i4i PDA supports translational projects developing innovative medical technology including medical devices, active implantable devices and in vitro diagnostic devices. i4i also supports projects which utilise and develop techniques or technologies from other industry sectors that could have a potential impact if applied in a healthcare setting.

Please find more details here.

Deadline for applications: 1pm on 05 June 2019.

Invention for Innovation (i4i): Challenge Awards 2019 – Real World Implementation

The NIHR i4i Challenge Awards Call 9 is inviting applications for the assessment of medtech innovations in healthcare settings. The aim is to shorten the evidence gap between the safety/preliminary efficacy typical of a newly CE marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment.

Please find more details here.

Application dates: 17 April 2019 to 12 June 2019.

Mechanisms of Action of Health Interventions

The EME Programme invites proposals for hypothesis driven research into the underlying mechanisms of action of clinical and public health interventions. Studies must utilise patients or samples from identifiable cohorts from current or completed NIHR-funded projects from the following programmes: i4i, EME (including the MRC/NIHR transferred portfolio), HS&DR, HTA, PHR, RfPB and PGfAR.

Please find more details here.

Deadline for applications: 1pm on 15 August 2019.

19/24 Efficacy and Mechanism Evaluation Programme – Researcher-Led

Applications are expected to set out programmes of work which may contain distinct stages. It is expected that the early stages of the study will, if successful, lead onto a full evaluative clinical
study or trial, which is in the remit of the EME Programme. This study must also be included and clearly specified within the application. Clinical trials embedded within the programme of work
must be large enough to detect a meaningful effect. Research in any disease area that represents a considerable burden of disease within the United Kingdom is eligible for consideration.

Please find more details here.

Deadline for applications: 1pm on 15 August 2019.

19/38 Scanning confocal ophthalmoscopy for diabetic eye screening

The aim of the HTA Programme is to ensure that high quality research information on the effectiveness, costs and broader impact of health technology is produced in the most efficient way for those who use, manage, provide care in or develop policy for the NHS.

What is the potential role for scanning confocal ophthalmoscopy in diabetic eye screening?
How does it affect the detection of retinopathy and would its use be cost-effective?

Please find more details here.

Deadline for applications: 1pm on 31 July 2019.

19/49 Call for Ambitious Data-Enabled Trials, Health Services and Public Health Research Studies

The HTA, HS&DR and PHR programmes are interested in funding studies using innovative data-enabled designs to answer pressing knowledge gaps for health, public health and, or social care evidence users, NHS patients, people with lived experience and, or policymakers.

Please find more details here.

Deadline for applications: 4 September 2019.

19/59 Health Technology Assessment Programme researcher-led primary research

The HTA programme is interested in funding proposals evaluating the clinical and cost effectiveness of a health technology. For diagnostic technologies, researchers may suggest equivalent
evaluations. They are interested in receiving proposals addressing any health problem in areas not otherwise well covered in their portfolio.

Please find more details here.

Deadline for applications: 1pm on 11 September 2019.

European Commission (Horizon 2020)

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

If you are thinking about applying for funding through the EU’s Horizon 2020 calls, please get in contact with your relevant National Contact Point who can advise you on how to form a consortium and how to apply for Horizon 2020 funding.

Here are some further links that you may find useful:

Other organisations

Organisation Focus Relevant grants
Diabetes UK Committed to improving the care and treatment of diabetes, preventing it from developing in those at risk and, ultimately, finding a cure. Project grants, clinical and basic research fellowships, PhD studentships, equipment grants, small grants, AHP nurse and midwife fellowships, travel fellowships.
Wellcome Trust Supports research into all aspects of biomedical science: from molecules and cells vital to life, through the spread of diseases or the vectors of disease across the globe, to clinical and public health research to improve the quality of healthcare. PhD studentships, fellowships, strategic awards, investigator awards.
Medical Research Council Dedicated to improving human health. By supporting research across the entire spectrum of medical sciences Studentships, fellowships, partnership grants, programme grants, biomedical catalyst grants, new investigator research grants.
Biological and Biotechnology Science Research Council Investing in world-class bioscience research and training on behalf of the UK public. Studentships, fellowships, new investigators, strategic awards, industry partnerships, international collaboration grants.
European Research Council Encourages high quality research in Europe through competitive funding. Starting grants, consolidator grants, advanced grants, synergy grants, proof of concept grants.
European Foundation for the Study of Diabetes Since its inception, EFSD has committed €88 million to diabetes research in Europe by various funding means. In the last five years, the Foundation has become a significant European funding agency for diabetes research, and is continually striving to enhance awareness in Europe of the severity and magnitude of this devastating condition. Programme grants: Request for Applications
Deadline for submission of applications: 1 July 2016
Diabetes Research and Wellness Foundation Research fellowships are given for research related to causes, cures or complications of diabetes. Occasionally, additional proposals which comply with the charity’s strategy for finding a cure for diabetes; improving treatment options and improving quality of life for people with diabetes will also be funded based on merit. Research fellowships, occasional additional proposals based on merit/funds being available.